Can Avarin (phenprocoumon) be taken concurrently with Gaviscon?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, you can safely take Avarin (phenprocoumon) and Gaviscon together

There is no documented drug interaction between phenprocoumon and Gaviscon (aluminum hydroxide/magnesium carbonate antacid), and these medications can be taken concurrently without dose adjustment.

Key Clinical Considerations

No Evidence of Interaction

The provided evidence extensively reviews phenprocoumon drug interactions, including interactions with antibiotics, NSAIDs, antiplatelet agents, and proton pump inhibitors 12. Notably absent from all documented interactions is any mention of antacids like Gaviscon affecting phenprocoumon efficacy or safety.

Gaviscon's General Precaution

The FDA label for Gaviscon includes a standard precaution stating "taking a prescription drug. Antacids may interact with certain prescription drugs" 3. However, this is a broad, non-specific warning that applies to potential interactions with some medications (typically through altered absorption), not a contraindication with anticoagulants.

Mechanism Analysis

  • Phenprocoumon is metabolized hepatically and has documented interactions primarily through:

    • Pharmacodynamic effects (bleeding risk with antiplatelet agents) 1
    • CYP enzyme interactions (with drugs like allopurinol, certain antibiotics) 14
  • Gaviscon works locally in the stomach as an antacid/alginate barrier and does not significantly affect hepatic metabolism or anticoagulant pharmacodynamics 5

Practical Recommendations

Take both medications as prescribed without timing separation. Unlike some anticoagulant interactions that require dose spacing (such as verapamil with dabigatran requiring 2-hour separation), no such precaution exists for phenprocoumon and antacids.

Important Monitoring

Continue routine INR monitoring as prescribed for your phenprocoumon therapy. The long half-life of phenprocoumon (5.27-5.29 days) 6 means any true drug interaction would manifest gradually over days to weeks, not acutely.

Common Pitfall to Avoid

Do not confuse this with proton pump inhibitor (PPI) interactions—while high-dose esomeprazole may slightly increase phenprocoumon effects 2, Gaviscon is an antacid with a completely different mechanism and does not share this interaction profile.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.